Literature DB >> 18383413

Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US.

Saralynn Allaire1, Frederick Wolfe, Jingbo Niu, Michael P Lavalley.   

Abstract

OBJECTIVE: To provide a contemporary estimate of the prevalence and incidence of rheumatoid arthritis (RA) work disability and examine its permanence over time.
METHODS: Data were collected semiannually from 5,384 subjects with rheumatologist-diagnosed RA. We examined prevalence in subgroups formed by approximately 5-year disease duration intervals using data from subjects age < or =64 years who were employed at disease onset. Annual incidence was examined longitudinally among subjects who supplied data in 2003, 2004, or 2005, were employed at disease onset and in a year's first survey, and were age < or =63 years. For work disability permanence we used longitudinal data from all subjects who became work disabled and observed whether they later returned to work.
RESULTS: Mean age of subjects was 52 years, 82% were female, 63% had more than a high school education, mean disease duration was 14 years, and mean Health Assessment Questionnaire score was 1.0. The prevalence of any premature work cessation was 23% in subjects with 1-3 years duration, 35% in those with 10 years, and 51% in those with > or =25 years RA duration. Arthritis-attributed work cessation was 14%, 29%, and 42%, respectively. Annual incidence of any premature work cessation was approximately 10% and arthritis-attributed work cessation incidence was approximately 6%. Thirty-nine percent of subjects who stopped working later returned to work.
CONCLUSION: Work disability prevalence in this sample was high (35% within 10 years disease duration), but may represent a decline from the 50% prevalence reported in 1987. Annual incidence of work disability was higher than prior studies, but the return to work rate was also higher.

Entities:  

Mesh:

Year:  2008        PMID: 18383413      PMCID: PMC3641514          DOI: 10.1002/art.23538

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys.

Authors:  S M M Verstappen; J W J Bijlsma; H Verkleij; E Buskens; A A M Blaauw; E J ter Borg; J W G Jacobs
Journal:  Arthritis Rheum       Date:  2004-06-15

2.  The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.

Authors:  J F Fries; P W Spitz; D Y Young
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

Review 3.  Update on work disability in rheumatic diseases.

Authors:  S H Allaire
Journal:  Curr Opin Rheumatol       Date:  2001-03       Impact factor: 5.006

Review 4.  Economic burden of rheumatoid arthritis: a systematic review.

Authors:  N J Cooper
Journal:  Rheumatology (Oxford)       Date:  2000-01       Impact factor: 7.580

5.  Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy.

Authors:  D M Kriegsman; B W Penninx; J T van Eijk; A J Boeke; D J Deeg
Journal:  J Clin Epidemiol       Date:  1996-12       Impact factor: 6.437

6.  Factors associated with continued employment among patients with rheumatoid arthritis: a survival model.

Authors:  S Reisine; J Fifield; S J Walsh; R Feinn
Journal:  J Rheumatol       Date:  2001-11       Impact factor: 4.666

7.  Therapeutic strategies in rheumatoid arthritis over a 40-year period.

Authors:  Hilal Maradit Kremers; Paulo Nicola; Cynthia S Crowson; W Michael O'Fallon; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

8.  The work dynamics of the person with rheumatoid arthritis.

Authors:  E Yelin; C Henke; W Epstein
Journal:  Arthritis Rheum       Date:  1987-05

9.  Work disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysis.

Authors:  S Reisine; J Fifield; S Walsh; D Dauser
Journal:  Arthritis Rheum       Date:  2007-04-15

10.  The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients.

Authors:  F Wolfe; D J Hawley
Journal:  J Rheumatol       Date:  1998-11       Impact factor: 4.666

View more
  23 in total

Review 1.  My treatment approach to rheumatoid arthritis.

Authors:  John M Davis; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

2.  A Multistakeholder Approach to Improving Quality in Rheumatoid Arthritis: Proceedings from the Rheumatoid Arthritis Quality Expert Medical Panel.

Authors:  Jeffrey R Curtis; C Kent Kwoh; Albert J Rizzoli; John A Welz
Journal:  Am Health Drug Benefits       Date:  2014-11

3.  Deficiencies in current evaluations of the cost-effectiveness of biologic agents for RA.

Authors:  Wilbert B van den Hout
Journal:  Nat Clin Pract Rheumatol       Date:  2008-12-23

4.  The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.

Authors:  Josefina Durán; Bernard Combe; Jingbo Niu; Nathalie Rincheval; Cécile Gaujoux-Viala; David T Felson
Journal:  Rheumatology (Oxford)       Date:  2015-07-14       Impact factor: 7.580

5.  Trends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providers.

Authors:  Rhonda Greenapple
Journal:  Am Health Drug Benefits       Date:  2012-03

6.  Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.

Authors:  Theresa M Hunter; Natalie N Boytsov; Xiang Zhang; Krista Schroeder; Kaleb Michaud; Andre B Araujo
Journal:  Rheumatol Int       Date:  2017-04-28       Impact factor: 2.631

7.  Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis.

Authors:  S J Bartlett; A K Gutierrez; A Butanis; V P Bykerk; J R Curtis; S Ginsberg; A L Leong; A Lyddiatt; W B Nowell; A M Orbai; K C Smith; C O Bingham
Journal:  Qual Life Res       Date:  2018-05-24       Impact factor: 4.147

Review 8.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 9.  Photodynamic therapy induces an immune response against a bacterial pathogen.

Authors:  Ying-Ying Huang; Masamitsu Tanaka; Daniela Vecchio; Maria Garcia-Diaz; Julie Chang; Yuji Morimoto; Michael R Hamblin
Journal:  Expert Rev Clin Immunol       Date:  2012-07       Impact factor: 4.473

10.  Facilitating empowerment in employees with chronic disease: qualitative analysis of the process of change.

Authors:  Inge Varekamp; Annelies Heutink; Selma Landman; Cees E M Koning; Gabe de Vries; Frank J H van Dijk
Journal:  J Occup Rehabil       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.